Becton, Dickinson and Co.  

(Public, NYSE:BDX)   Watch this stock  
Find more results for BDX
-0.06 (-0.04%)
Real-time:   11:39AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 144.73 - 146.07
52 week 111.07 - 149.98
Open 145.36
Vol / Avg. 243,569.00/1.33M
Mkt cap 30.40B
P/E 24.97
Div/yield 0.60/1.65
EPS 5.83
Shares 208.81M
Beta 0.87
Inst. own 80%
Apr 29, 2015
Q2 2015 Becton Dickinson and Co Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Mar 10, 2015
Becton Dickinson and Co at Barclays Healthcare Conference - Webcast
Feb 5, 2015
Q1 2015 Becton Dickinson and Co Earnings Release
Feb 5, 2015
Q1 2015 Becton Dickinson and Co Earnings Call - Webcast
Jan 28, 2015
Becton Dickinson and Co Annual Shareholders Meeting (Estimated)
Jan 27, 2015
Becton Dickinson and Co Annual Shareholders Meeting - Webcast
Jan 14, 2015
Becton Dickinson and Co at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 11.46% 14.03%
Operating margin 17.02% 19.01%
EBITD margin - 25.67%
Return on average assets 6.09% 9.64%
Return on average equity 18.71% 23.47%
Employees 30,619 -
CDP Score - 92 B


One Becton Dr
United States - Map
+1-201-8476800 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Becton Dickinson and Co. is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company's operations consist of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The BD Medical segment manufactures syringes, needles and other products used in a range of healthcare settings. The BD Diagnostics segment collects and transport diagnostics specimens. The BD Biosciences segment produces clinical research tools that aid discovery and development of new drugs and vaccines.

Officers and directors

Vincent A. Forlenza Chairman of the Board, President, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Christopher R. Reidy Chief Financial Officer, Executive Vice President, Principal Accounting Officer
Age: 57
Bio & Compensation  - Reuters
Alexandre Conroy President, Europe, EMA and the Americas
Age: 50
Bio & Compensation  - Reuters
James Lim President, Greater Asia
Age: 49
Bio & Compensation  - Reuters
William A. Kozy Chief Operating Officer, Executive Vice President
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Gary M. Cohen Executive Vice President
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Nabil Shabshab Senior Vice President, Chief Marketing Officer
Age: 48
Bio & Compensation  - Reuters
Jeffrey S. Sherman Senior Vice President, General Counsel
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jerome V. Hurwitz Senior Vice President - Human Resources
Age: 59
Bio & Compensation  - Reuters
Stephen Sichak Jr. Senior Vice President - Integrated Supply Chain
Age: 56
Bio & Compensation  - Reuters